26 August 2022 : Original article
Development of a Novel Model for Predicting Postoperative Short-Term Outcome in Patients with Hepatitis B-Related Acute-on-Chronic Liver Failure Undergoing Liver Transplantation
Qikun Zhang12ABCDEF*, Menglong Wang2ADF, Guangming Li2BDG, Zhongtao Zhang1ADEDOI: 10.12659/AOT.936732
Ann Transplant 2022; 27:e936732
Supplementary Table 1 The formula of 16 scoring models.
| Models | Formula (parameter) |
|---|---|
| CTP(Child-Pugh) | Bilirubin, Albumin, Prothrombin time, Encephalopathy, Ascites |
| UNOS-MELD | (0.957×Loge[creatinine mg/dl]+0.378×Loge[total bilirubin mg/dl]+1.120×Loge[INR]+ 0.643)×10 |
| Updated-MELD | 1.266 loge(1+creatinine)+0.939 loge(1+bilirubin)+1.658 loge(1+INR) |
| Integrated-MELD | MELD+(0.3×age)-(0.7×Na)+100 |
| MELD-Na | MELD+1.59×(135-Na) (Na 120mmo/L~135 mmo/L) |
| MLED Na | MELD−Na−[0.025×MELD×(140−Na)]+140 (Na 125 mmo/L~140 mmo/L) |
| CLIF-SOFA | Respiration (PaO/FiO or SpO/FiO), Coagulation (INR), Liver (Bilirubin), Cardiovascular (MAP/dopamine or dobutamine or terlipressin or epinephrine or norepinephrine), CNS (HE grade), Renal (Creatinine) |
| CLIF-OFs | Liver (bilirubin), Kidney (creatinine), Brain (West-Haven grade for HE), Coagulation (INR), Circulatory (MAP/use of vasopressors), Respiratory (PaO/FiO or SpO/FiO) |
| CLIF-C ACLFs | 10×[0.33×CLIF-OFs+0.04×Age+0.63×In (WBC count)-2] |
| CLIF-C ADs | 10×0.03×Age(years)+0.66×Ln(Creatinine(mg/dL))+1.71×Ln(INR)+0.88×In(WBC(10 cells/L))−0.05× Sodium (mmol/L)+8 |
| Refit MELD | 4.082×Loge (bilirubinc)+8.485×Loge (creatiinec)+10.671×Loge (INRC)+7.432 |
| Refit MELD Na | 4.258×Loge (bilirubinc)+6.792 Loge (creatiinec)+8.290×Loge (INRC)+0.652×(140-Nac)-0.194× (140-Nac)×Bilicc+6.327 |
| MELD-AS | MELD+4.53×(sodium |
| Zheng’s Risk | −2.3090+0.3600×Creatinine (mg/dl)+0.5493×(need for hemodialysis [0, 1])+0.7000×(moderate ascites [0, 1]) |
| UKELD | [(5.395×Ln(INR))+(1.485×Ln (creatinine))+(3.130×Ln (bilirubin))−(81.565×Ln (sodium))]+435 |
| MESO | (MELD Score/Serum Sodium)×10 |